Literature DB >> 29970621

Prognosis of asymptomatic intracranial hemorrhage after endovascular treatment.

Yonggang Hao1,2, Wenhua Liu3, Huaiming Wang4,5, Wenjie Zi6, Dong Yang4, Wei Wang7, Xiguang Tian8, Fuqiang Guo9, Ping Jin10, Yunyun Xiong6, Xinfeng Liu1,4,6, Gelin Xu1,4,6.   

Abstract

OBJECTIVE: Asymptomatic intracranial hemorrhage (aSICH) is a common phenomenon after endovascular treatment of acute ischemic stroke, but its prognostic impacts remain unclear. This study evaluated functional outcomes of thrombectomy in patients with and without aSICH.
METHODS: Patients with acute ischemic stroke due to large artery occlusion in the anterior circulation who were treated with thrombectomy were enrolled in 21 centers. According to CT scans performed within 72 hours of endovascular procedures, patients with aSICH or without intracranial hemorrhage were included while patients with symptomatic intracranial hemorrhage (SICH) were excluded. Baseline data and functional outcomes were compared between patients with aSICH and those without intracranial hemorrhage. Logistic regression analysis was applied to evaluate the impacts of aSICH on functional outcomes.
RESULTS: Of the 632 patients with endovascular treatment, 101 (16.0%) were classified as having SICH, 212 (33.5%) as having aSICH, and 319 (50.5%) as being without intracranial hemorrhage. Patients with aSICH after endovascular treatment had a lower ratio of excellent outcome (mRS 0-1, OR 0.53; 95% CI 0.33 to 0.84, P=0.007) than those without intracranial hemorrhage. There were no significant differences concerning favorable outcome (mRS 0-2, OR 0.76; 95% CI 0.50 to 1.14, P=0.185) or mortality (OR 0.64; 95% CI 0.38 to 1.09, P=0.101) between patients with aSICH and those without intracranial hemorrhage.
CONCLUSIONS: In an Asian population, aSICH after thrombectomy may decrease the likelihood of an excellent functional outcome but does not influence a favorable outcome and mortality in patients with ischemic stroke due to large artery occlusion in the anterior circulation. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  hemorrhage; stroke; thrombectomy

Mesh:

Year:  2018        PMID: 29970621     DOI: 10.1136/neurintsurg-2018-013848

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  7 in total

1.  Clinical relevance of asymptomatic intracerebral hemorrhage post thrombectomy depends on angiographic collateral score.

Authors:  Jawed Nawabi; Helge Kniep; Gabriel Broocks; Tobias D Faizy; Gerhard Schön; G Thomalla; Jens Fiehler; Uta Hanning
Journal:  J Cereb Blood Flow Metab       Date:  2019-08-21       Impact factor: 6.200

Review 2.  Prognosis associated with asymptomatic intracranial hemorrhage after acute ischemic stroke: a systematic review and meta-analysis.

Authors:  Guoyi Tang; Zhixin Cao; Yuting Luo; Shaoqing Wu; Xunsha Sun
Journal:  J Neurol       Date:  2022-03-08       Impact factor: 4.849

3.  Effect of supraglottic airway devices versus endotracheal intubation general anesthesia on outcomes in patients undergoing mechanical thrombectomy: A prospective randomized clinical trial.

Authors:  Jing Zhao; Wenchao Zhu; Yingying Qi; Guangjun Xu; Lei Liu; Jingjing Liu
Journal:  Medicine (Baltimore)       Date:  2022-05-06       Impact factor: 1.817

Review 4.  Intracranial Hemorrhage After Reperfusion Therapies in Acute Ischemic Stroke Patients.

Authors:  Benjamin Maïer; Jean Philippe Desilles; Mikael Mazighi
Journal:  Front Neurol       Date:  2020-12-11       Impact factor: 4.003

Review 5.  Stroke Treatment With PAR-1 Agents to Decrease Hemorrhagic Transformation.

Authors:  Patrick D Lyden; Kent E Pryor; Jennifer Minigh; Thomas P Davis; John H Griffin; Howard Levy; Berislav V Zlokovic
Journal:  Front Neurol       Date:  2021-03-15       Impact factor: 4.003

6.  Dual thrombolytic therapy with mutant pro-urokinase and small bolus alteplase for ischemic stroke (DUMAS): study protocol for a multicenter randomized controlled phase II trial.

Authors:  Nadinda A M van der Ende; Bob Roozenbeek; Lucas E M Smagge; Sven P R Luijten; Leo A M Aerden; Petra Kraayeveld; Ido R van den Wijngaard; Geert J Lycklama À Nijeholt; Heleen M den Hertog; H Zwenneke Flach; Alexis C Wallace; Victor Gurewich; Gregory J Del Zoppo; William J Meurer; Hester F Lingsma; Aad van der Lugt; Diederik W J Dippel
Journal:  Trials       Date:  2022-08-09       Impact factor: 2.728

7.  Interaction Effect of Baseline Serum Glucose and Early Ischemic Water Uptake on the Risk of Secondary Hemorrhage After Ischemic Stroke.

Authors:  Jawed Nawabi; Sarah Elsayed; Henriette Scholz; André Kemmling; Lukas Meyer; Helge Kniep; Matthias Bechstein; Fabian Flottmann; Tobias D Faizy; Gerhard Schön; Jens Fiehler; Uta Hanning; Gabriel Broocks
Journal:  Front Neurol       Date:  2021-07-08       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.